Hourglass Capital, LLC Reata Pharmaceuticals Inc Transaction History

Hourglass Capital, LLC

  • $359 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$100.0 - $143.02 $2.18 Million - $3.12 Million
-21,842 Closed
0 $0
Q4 2019

Feb 12, 2020
SELL
$74.57 - $217.92 $407,226 - $1.19 Million
-5,461 Reduced 20.0%
21,842 $4.47 Million
Q4 2018

Feb 08, 2019
BUY
$48.76 - $76.44 $1.33 Million - $2.09 Million
27,303 New
27,303 $1.53 Million

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Hourglass Capital, LLC Portfolio

Follow Hourglass Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hourglass Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hourglass Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email